Literature DB >> 8236392

A prospective study of the influence of alpha thalassaemia on morbidity from malaria and immune responses to defined Plasmodium falciparum antigens in Gambian children.

S J Allen1, P Rowe, C E Allsopp, E M Riley, P H Jakobsen, A V Hill, B M Greenwood.   

Abstract

The protective effect of alpha thalassaemia (-alpha/alpha alpha) against morbidity from falciparum malaria was assessed in a prospective study of rural Gambian children. The gene frequency for single alpha-globin gene deletions was 0.12. Malariometric indices measured during cross-sectional surveys and morbidity from malaria determined by weekly surveillance were similar in children with alpha thalassaemia and in those with a normal alpha-globin genotype. However, the small number of children who carried both alpha thalassaemia and the sickle cell trait had fewer clinical episodes of malaria than children with the sickle cell trait alone. Specific antibody responses and cell-mediated immune responses in vitro to defined Plasmodium falciparum antigens were measured in children participating in the study. In general, there was no evidence of an increased prevalence or intensity of humoral or cell-mediated immune responses to the malaria antigens studied in children heterozygous for alpha thalassaemia compared with children with a normal alpha-globin genotype.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8236392     DOI: 10.1016/0035-9203(93)90129-e

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  7 in total

Review 1.  Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis.

Authors:  Steve M Taylor; Christian M Parobek; Rick M Fairhurst
Journal:  Lancet Infect Dis       Date:  2012-03-23       Impact factor: 25.071

2.  alpha+-Thalassemia protects children against disease caused by other infections as well as malaria.

Authors:  S J Allen; A O'Donnell; N D Alexander; M P Alpers; T E Peto; J B Clegg; D J Weatherall
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

3.  Negative epistasis between the malaria-protective effects of alpha+-thalassemia and the sickle cell trait.

Authors:  Thomas N Williams; Tabitha W Mwangi; Sammy Wambua; Timothy E A Peto; David J Weatherall; Sunetra Gupta; Mario Recker; Bridget S Penman; Sophie Uyoga; Alex Macharia; Jedidah K Mwacharo; Robert W Snow; Kevin Marsh
Journal:  Nat Genet       Date:  2005-10-16       Impact factor: 38.330

4.  Effect of α(+)-thalassaemia on episodes of fever due to malaria and other causes: a community-based cohort study in Tanzania.

Authors:  Jacobien Veenemans; Esther J S Jansen; Amrish Y Baidjoe; Erasto V Mbugi; Ayşe Y Demir; Rob J Kraaijenhagen; Huub F J Savelkoul; Hans Verhoef
Journal:  Malar J       Date:  2011-09-22       Impact factor: 2.979

5.  Epistasis between the haptoglobin common variant and α+thalassemia influences risk of severe malaria in Kenyan children.

Authors:  Sarah H Atkinson; Sophie M Uyoga; Emily Nyatichi; Alex W Macharia; Gideon Nyutu; Carolyne Ndila; Dominic P Kwiatkowski; Kirk A Rockett; Thomas N Williams
Journal:  Blood       Date:  2014-01-29       Impact factor: 22.113

6.  α-Thalassemia impairs the cytoadherence of Plasmodium falciparum-infected erythrocytes.

Authors:  Michael A Krause; Seidina A S Diakite; Tatiana M Lopera-Mesa; Chanaki Amaratunga; Takayuki Arie; Karim Traore; Saibou Doumbia; Drissa Konate; Jeffrey R Keefer; Mahamadou Diakite; Rick M Fairhurst
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

7.  Host erythrocyte polymorphisms and exposure to Plasmodium falciparum in Papua New Guinea.

Authors:  Freya J I Fowkes; Pascal Michon; Lynn Pilling; Ruth M Ripley; Livingstone Tavul; Heather J Imrie; Caira M Woods; Charles S Mgone; Adrian J F Luty; Karen P Day
Journal:  Malar J       Date:  2008-01-03       Impact factor: 2.979

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.